LNC Therapeutics

LNC Therapeutics

LNC Therapeutics is the 1st company to harness the therapeutic potential of Christensenella. We have been focused on the fundamental causes of illnesses

A former researcher at the Institut Pasteur, Georges was Vice-President of Business Development & Intellectual Property and a member of the management team at Celyad.

Sandrine joined LNC Therapeutics in 2017 as Chief Scientific Officer and is also Associate Professor in Integrative Metabolism in the department of Food and Nutritional Sciences at the University of Reading.

An experienced CFO, Fabrice decided to switch gears after gaining extensive experience as a financial auditor, getting involved in operations at a number of pharmaceutical SMEs, where he successfully headed up change management processes.

We are looking for preclinical and clinical project manager | WHAT WE OFFER An exciting opportunity to dive in and begin...

Chaque semaine, Maddyness dresse le bilan des levées de fonds de la semaine qui vient de s'écouler. Cette semaine,...

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
LNC Therapeutics funding round, September 2017
7,700,000
September 2017
1 Result
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.